Is Emergent BioSolutions, Inc. overvalued or undervalued?

Sep 20 2025 06:11 PM IST
share
Share Via
As of August 6, 2025, Emergent BioSolutions, Inc. has improved from a risky to an attractive valuation grade, indicating it may be undervalued with a current price of $7.94, a Price to Book Value of 0.67, and an EV to EBITDA of 14.99, suggesting potential for recovery and growth compared to its peers.
As of 6 August 2025, the valuation grade for Emergent BioSolutions, Inc. has moved from risky to attractive, indicating a significant improvement in its investment appeal. The company appears to be undervalued, especially when considering its Price to Book Value of 0.67, EV to Sales ratio of 0.91, and EV to EBITDA of 14.99. In comparison, peers such as Fusion Pharmaceuticals, Inc. exhibit a risky valuation with an EV to EBITDA of -15.5851, while Rigel Pharmaceuticals, Inc. is rated very attractive with an EV to EBITDA of 6.4016.

Despite the lack of return data for the company, its recent valuation change suggests a positive outlook compared to the broader market. The current price of $7.94, alongside a notable 52-week high of $12.73, reinforces the notion that the stock may be positioned for recovery and growth.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News